Ascendis Pharma Investigational Site

Oklahoma City, Oklahoma 73104

1 studies enrolling now · 5 studies all time

What they study most

2L+ Cervical Cancer, Advanced Solid Tumor, Endocrine System Diseases, Growth Hormone Deficiency, Pediatric, Hormone Deficiency, Hormones, Idiopathic Short Stature, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Melanoma, Neoadjuvant Non-Small Cell Lung Cancer, Pituitary Diseases

Studies at this site

• Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders — Recruiting now
• A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) — Completed
• A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial — Completed
• A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome — Running, not enrolling
• A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling